nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—AMN—Lipoprotein metabolism—HSPG2—systemic scleroderma	0.0161	0.0544	CbGpPWpGaD
Hydroxocobalamin—CUBN—Lipoprotein metabolism—HSPG2—systemic scleroderma	0.0142	0.0479	CbGpPWpGaD
Hydroxocobalamin—MMACHC—lung—systemic scleroderma	0.0129	0.0643	CbGeAlD
Hydroxocobalamin—AMN—digestive system—systemic scleroderma	0.0127	0.0634	CbGeAlD
Hydroxocobalamin—TCN2—connective tissue—systemic scleroderma	0.012	0.0597	CbGeAlD
Hydroxocobalamin—CUBN—digestive system—systemic scleroderma	0.0107	0.0533	CbGeAlD
Hydroxocobalamin—AMN—Lipid and lipoprotein metabolism—HSPG2—systemic scleroderma	0.0107	0.0361	CbGpPWpGaD
Hydroxocobalamin—AMN—lung—systemic scleroderma	0.0106	0.0529	CbGeAlD
Hydroxocobalamin—CASP9—Rac1/Pak1/p38/MMP-2 pathway—TNIP1—systemic scleroderma	0.0098	0.0331	CbGpPWpGaD
Hydroxocobalamin—TCN1—digestive system—systemic scleroderma	0.00963	0.048	CbGeAlD
Hydroxocobalamin—MUT—connective tissue—systemic scleroderma	0.00942	0.047	CbGeAlD
Hydroxocobalamin—CUBN—Lipid and lipoprotein metabolism—HSPG2—systemic scleroderma	0.00941	0.0318	CbGpPWpGaD
Hydroxocobalamin—TCN2—digestive system—systemic scleroderma	0.00865	0.0431	CbGeAlD
Hydroxocobalamin—MTRR—connective tissue—systemic scleroderma	0.00847	0.0422	CbGeAlD
Hydroxocobalamin—MMAA—lung—systemic scleroderma	0.00845	0.0421	CbGeAlD
Hydroxocobalamin—TCN2—tendon—systemic scleroderma	0.00823	0.041	CbGeAlD
Hydroxocobalamin—TCN1—lung—systemic scleroderma	0.00804	0.0401	CbGeAlD
Hydroxocobalamin—MMAB—lung—systemic scleroderma	0.00792	0.0395	CbGeAlD
Hydroxocobalamin—CASP9—lung—systemic scleroderma	0.0074	0.0369	CbGeAlD
Hydroxocobalamin—MTR—connective tissue—systemic scleroderma	0.00738	0.0368	CbGeAlD
Hydroxocobalamin—TCN2—lung—systemic scleroderma	0.00723	0.036	CbGeAlD
Hydroxocobalamin—MUT—digestive system—systemic scleroderma	0.0068	0.0339	CbGeAlD
Hydroxocobalamin—MTRR—Folate Metabolism—CSF1—systemic scleroderma	0.00678	0.0229	CbGpPWpGaD
Hydroxocobalamin—CASP9—Caspase Cascade in Apoptosis—TOP1—systemic scleroderma	0.00657	0.0222	CbGpPWpGaD
Hydroxocobalamin—MUT—tendon—systemic scleroderma	0.00648	0.0323	CbGeAlD
Hydroxocobalamin—MTRR—digestive system—systemic scleroderma	0.00611	0.0305	CbGeAlD
Hydroxocobalamin—CASP9—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CD247—systemic scleroderma	0.00601	0.0203	CbGpPWpGaD
Hydroxocobalamin—CASP9—NOD1/2 Signaling Pathway—TNFAIP3—systemic scleroderma	0.00591	0.02	CbGpPWpGaD
Hydroxocobalamin—MTRR—tendon—systemic scleroderma	0.00582	0.029	CbGeAlD
Hydroxocobalamin—MUT—lung—systemic scleroderma	0.00568	0.0283	CbGeAlD
Hydroxocobalamin—MTR—Folate Metabolism—CSF1—systemic scleroderma	0.00553	0.0187	CbGpPWpGaD
Hydroxocobalamin—MTR—digestive system—systemic scleroderma	0.00533	0.0266	CbGeAlD
Hydroxocobalamin—MTRR—lung—systemic scleroderma	0.00511	0.0255	CbGeAlD
Hydroxocobalamin—MTR—tendon—systemic scleroderma	0.00508	0.0253	CbGeAlD
Hydroxocobalamin—MMAB—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.0047	0.0159	CbGpPWpGaD
Hydroxocobalamin—TCN1—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.0047	0.0159	CbGpPWpGaD
Hydroxocobalamin—MTR—lung—systemic scleroderma	0.00445	0.0222	CbGeAlD
Hydroxocobalamin—TCN2—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.00437	0.0148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—TNFAIP3—systemic scleroderma	0.00403	0.0136	CbGpPWpGaD
Hydroxocobalamin—CASP9—p75(NTR)-mediated signaling—RHOB—systemic scleroderma	0.00389	0.0131	CbGpPWpGaD
Hydroxocobalamin—MUT—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.00372	0.0126	CbGpPWpGaD
Hydroxocobalamin—MMAB—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.00356	0.012	CbGpPWpGaD
Hydroxocobalamin—TCN1—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.00356	0.012	CbGpPWpGaD
Hydroxocobalamin—CUBN—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.00343	0.0116	CbGpPWpGaD
Hydroxocobalamin—TCN2—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.00331	0.0112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—IRF5—systemic scleroderma	0.00298	0.0101	CbGpPWpGaD
Hydroxocobalamin—CASP9—FAS pathway and Stress induction of HSP regulation—IL1A—systemic scleroderma	0.00294	0.00992	CbGpPWpGaD
Hydroxocobalamin—MMAA—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	0.00291	0.00983	CbGpPWpGaD
Hydroxocobalamin—MUT—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.00282	0.00952	CbGpPWpGaD
Hydroxocobalamin—MTRR—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.00282	0.00951	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—IL13—systemic scleroderma	0.00281	0.00951	CbGpPWpGaD
Hydroxocobalamin—MUT—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	0.00277	0.00937	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—SMAD7—systemic scleroderma	0.00269	0.00908	CbGpPWpGaD
Hydroxocobalamin—CUBN—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.0026	0.00879	CbGpPWpGaD
Hydroxocobalamin—CASP9—GAB1 signalosome—CSK—systemic scleroderma	0.00259	0.00875	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.0025	0.00844	CbGpPWpGaD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—TNFAIP3—systemic scleroderma	0.00248	0.00837	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—BLK—systemic scleroderma	0.00247	0.00834	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Cancer Pathway—MMP1—systemic scleroderma	0.00239	0.00808	CbGpPWpGaD
Hydroxocobalamin—MTR—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.0023	0.00776	CbGpPWpGaD
Hydroxocobalamin—MTRR—Folate Metabolism—CCL2—systemic scleroderma	0.00229	0.00774	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—CTLA4—systemic scleroderma	0.00226	0.00765	CbGpPWpGaD
Hydroxocobalamin—MTRR—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.00214	0.00722	CbGpPWpGaD
Hydroxocobalamin—MTR—Folate Metabolism—CCL2—systemic scleroderma	0.00187	0.00631	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—HLA-DQB1—systemic scleroderma	0.00186	0.0063	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—IL1A—systemic scleroderma	0.00177	0.00598	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—CD40LG—systemic scleroderma	0.00176	0.00595	CbGpPWpGaD
Hydroxocobalamin—MTR—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.00174	0.00588	CbGpPWpGaD
Hydroxocobalamin—MTRR—Folate Metabolism—IL1B—systemic scleroderma	0.00174	0.00587	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—CSK—systemic scleroderma	0.00165	0.00558	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—CSK—systemic scleroderma	0.00164	0.00553	CbGpPWpGaD
Hydroxocobalamin—CASP9—NOD pathway—IL1B—systemic scleroderma	0.00156	0.00527	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.00153	0.00516	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.00153	0.00516	CbGpPWpGaD
Hydroxocobalamin—Chills—Leflunomide—systemic scleroderma	0.00152	0.00302	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Leflunomide—systemic scleroderma	0.00151	0.003	CcSEcCtD
Hydroxocobalamin—Eye disorder—Mycophenolic acid—systemic scleroderma	0.00151	0.003	CcSEcCtD
Hydroxocobalamin—Discomfort—Captopril—systemic scleroderma	0.0015	0.00299	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.0015	0.00298	CcSEcCtD
Hydroxocobalamin—MTR—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.00148	0.00501	CbGpPWpGaD
Hydroxocobalamin—Mental disorder—Leflunomide—systemic scleroderma	0.00148	0.00295	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Mometasone—systemic scleroderma	0.00148	0.00294	CcSEcCtD
Hydroxocobalamin—MMACHC—Disease—SMAD7—systemic scleroderma	0.00147	0.00497	CbGpPWpGaD
Hydroxocobalamin—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00147	0.00291	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Mometasone—systemic scleroderma	0.00146	0.00291	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Captopril—systemic scleroderma	0.00146	0.0029	CcSEcCtD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.00146	0.00493	CbGpPWpGaD
Hydroxocobalamin—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.00146	0.00289	CcSEcCtD
Hydroxocobalamin—Chills—Mycophenolic acid—systemic scleroderma	0.00145	0.00288	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00145	0.00288	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00144	0.00287	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Lisinopril—systemic scleroderma	0.00144	0.00285	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Lisinopril—systemic scleroderma	0.00143	0.00285	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Lisinopril—systemic scleroderma	0.00143	0.00283	CcSEcCtD
Hydroxocobalamin—Tachycardia—Captopril—systemic scleroderma	0.00142	0.00283	CcSEcCtD
Hydroxocobalamin—Pain—Mometasone—systemic scleroderma	0.00142	0.00282	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00142	0.00282	CcSEcCtD
Hydroxocobalamin—MTR—Folate Metabolism—IL1B—systemic scleroderma	0.00142	0.00479	CbGpPWpGaD
Hydroxocobalamin—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00142	0.00281	CcSEcCtD
Hydroxocobalamin—Malaise—Azathioprine—systemic scleroderma	0.00141	0.0028	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Prednisone—systemic scleroderma	0.00138	0.00274	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00137	0.00272	CcSEcCtD
Hydroxocobalamin—Pruritus—Pentoxifylline—systemic scleroderma	0.00136	0.00271	CcSEcCtD
Hydroxocobalamin—Angioedema—Leflunomide—systemic scleroderma	0.00135	0.00268	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.00135	0.00455	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—SMAD7—systemic scleroderma	0.00134	0.00454	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—SMAD7—systemic scleroderma	0.00134	0.00454	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—TGFBI—systemic scleroderma	0.00134	0.00454	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—BLK—systemic scleroderma	0.00134	0.00453	CbGpPWpGaD
Hydroxocobalamin—CASP9—AGE/RAGE pathway—MMP2—systemic scleroderma	0.00134	0.00452	CbGpPWpGaD
Hydroxocobalamin—Malaise—Leflunomide—systemic scleroderma	0.00133	0.00264	CcSEcCtD
Hydroxocobalamin—Angiopathy—Lisinopril—systemic scleroderma	0.00132	0.00262	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00132	0.00262	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00132	0.00262	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Mometasone—systemic scleroderma	0.00131	0.00261	CcSEcCtD
Hydroxocobalamin—Discomfort—Azathioprine—systemic scleroderma	0.00131	0.00261	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00131	0.0026	CcSEcCtD
Hydroxocobalamin—Chills—Lisinopril—systemic scleroderma	0.00131	0.00259	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.0013	0.00259	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Captopril—systemic scleroderma	0.0013	0.00258	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Lisinopril—systemic scleroderma	0.0013	0.00258	CcSEcCtD
Hydroxocobalamin—Agitation—Mycophenolic acid—systemic scleroderma	0.00129	0.00257	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Captopril—systemic scleroderma	0.00128	0.00255	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Methotrexate—systemic scleroderma	0.00128	0.00254	CcSEcCtD
Hydroxocobalamin—Mental disorder—Lisinopril—systemic scleroderma	0.00127	0.00253	CcSEcCtD
Hydroxocobalamin—Dizziness—Pentoxifylline—systemic scleroderma	0.00127	0.00253	CcSEcCtD
Hydroxocobalamin—Malaise—Mycophenolic acid—systemic scleroderma	0.00127	0.00252	CcSEcCtD
Hydroxocobalamin—Erythema—Lisinopril—systemic scleroderma	0.00127	0.00252	CcSEcCtD
Hydroxocobalamin—Infection—Azathioprine—systemic scleroderma	0.00127	0.00251	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00126	0.0025	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00249	CcSEcCtD
Hydroxocobalamin—Chest pain—Leflunomide—systemic scleroderma	0.00125	0.00249	CcSEcCtD
Hydroxocobalamin—CASP9—AGE/RAGE pathway—NOS3—systemic scleroderma	0.00125	0.00423	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—SMAD7—systemic scleroderma	0.00125	0.00422	CbGpPWpGaD
Hydroxocobalamin—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00248	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00125	0.00248	CcSEcCtD
Hydroxocobalamin—Discomfort—Leflunomide—systemic scleroderma	0.00124	0.00246	CcSEcCtD
Hydroxocobalamin—Skin disorder—Azathioprine—systemic scleroderma	0.00124	0.00246	CcSEcCtD
Hydroxocobalamin—TCN1—Disease—TGFBI—systemic scleroderma	0.00123	0.00415	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—TGFBI—systemic scleroderma	0.00123	0.00415	CbGpPWpGaD
Hydroxocobalamin—Rash—Pentoxifylline—systemic scleroderma	0.00121	0.00241	CcSEcCtD
Hydroxocobalamin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00121	0.00241	CcSEcCtD
Hydroxocobalamin—Headache—Pentoxifylline—systemic scleroderma	0.00121	0.0024	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.0012	0.00239	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Captopril—systemic scleroderma	0.0012	0.00239	CcSEcCtD
Hydroxocobalamin—Chest pain—Mycophenolic acid—systemic scleroderma	0.0012	0.00238	CcSEcCtD
Hydroxocobalamin—Infection—Leflunomide—systemic scleroderma	0.0012	0.00237	CcSEcCtD
Hydroxocobalamin—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00237	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00119	0.00236	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Prednisone—systemic scleroderma	0.00119	0.00236	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00235	CcSEcCtD
Hydroxocobalamin—Discomfort—Mycophenolic acid—systemic scleroderma	0.00118	0.00235	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Leflunomide—systemic scleroderma	0.00118	0.00234	CcSEcCtD
Hydroxocobalamin—Pruritus—Mometasone—systemic scleroderma	0.00118	0.00234	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00118	0.00233	CcSEcCtD
Hydroxocobalamin—Tachycardia—Leflunomide—systemic scleroderma	0.00117	0.00233	CcSEcCtD
Hydroxocobalamin—Skin disorder—Leflunomide—systemic scleroderma	0.00117	0.00232	CcSEcCtD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.00116	0.00391	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.00116	0.00391	CbGpPWpGaD
Hydroxocobalamin—Angioedema—Lisinopril—systemic scleroderma	0.00116	0.0023	CcSEcCtD
Hydroxocobalamin—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00116	0.0023	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Captopril—systemic scleroderma	0.00115	0.00229	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00228	CcSEcCtD
Hydroxocobalamin—Oedema—Mycophenolic acid—systemic scleroderma	0.00115	0.00228	CcSEcCtD
Hydroxocobalamin—Nausea—Pentoxifylline—systemic scleroderma	0.00114	0.00227	CcSEcCtD
Hydroxocobalamin—Chills—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00227	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—TGFBI—systemic scleroderma	0.00114	0.00386	CbGpPWpGaD
Hydroxocobalamin—Malaise—Lisinopril—systemic scleroderma	0.00114	0.00227	CcSEcCtD
Hydroxocobalamin—Infection—Mycophenolic acid—systemic scleroderma	0.00114	0.00226	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00226	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Mometasone—systemic scleroderma	0.00114	0.00226	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Prednisone—systemic scleroderma	0.00114	0.00226	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00113	0.00224	CcSEcCtD
Hydroxocobalamin—MTR—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.00113	0.0038	CbGpPWpGaD
Hydroxocobalamin—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00112	0.00222	CcSEcCtD
Hydroxocobalamin—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00222	CcSEcCtD
Hydroxocobalamin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00111	0.00221	CcSEcCtD
Hydroxocobalamin—MMAA—Disease—SMAD7—systemic scleroderma	0.00111	0.00376	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—SMAD7—systemic scleroderma	0.00111	0.00376	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.0011	0.00373	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.0011	0.00218	CcSEcCtD
Hydroxocobalamin—Chest pain—Lisinopril—systemic scleroderma	0.00108	0.00214	CcSEcCtD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—CCL2—systemic scleroderma	0.00108	0.00364	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Leflunomide—systemic scleroderma	0.00107	0.00213	CcSEcCtD
Hydroxocobalamin—MMACHC—Disease—HSPG2—systemic scleroderma	0.00107	0.00362	CbGpPWpGaD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00107	0.00213	CcSEcCtD
Hydroxocobalamin—Discomfort—Lisinopril—systemic scleroderma	0.00107	0.00212	CcSEcCtD
Hydroxocobalamin—MUT—Disease—SMAD7—systemic scleroderma	0.00106	0.00359	CbGpPWpGaD
Hydroxocobalamin—Dyspepsia—Leflunomide—systemic scleroderma	0.00106	0.0021	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Azathioprine—systemic scleroderma	0.00105	0.00209	CcSEcCtD
Hydroxocobalamin—Rash—Mometasone—systemic scleroderma	0.00105	0.00208	CcSEcCtD
Hydroxocobalamin—Dermatitis—Mometasone—systemic scleroderma	0.00105	0.00208	CcSEcCtD
Hydroxocobalamin—Headache—Mometasone—systemic scleroderma	0.00104	0.00207	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00104	0.00206	CcSEcCtD
Hydroxocobalamin—MMACHC—Disease—CSK—systemic scleroderma	0.00104	0.0035	CbGpPWpGaD
Hydroxocobalamin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00103	0.00205	CcSEcCtD
Hydroxocobalamin—Oedema—Lisinopril—systemic scleroderma	0.00103	0.00205	CcSEcCtD
Hydroxocobalamin—Pruritus—Captopril—systemic scleroderma	0.00103	0.00205	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00205	CcSEcCtD
Hydroxocobalamin—Pain—Leflunomide—systemic scleroderma	0.00103	0.00204	CcSEcCtD
Hydroxocobalamin—Infection—Lisinopril—systemic scleroderma	0.00103	0.00204	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00102	0.00203	CcSEcCtD
Hydroxocobalamin—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00203	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.00102	0.00344	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—TGFBI—systemic scleroderma	0.00102	0.00344	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—TGFBI—systemic scleroderma	0.00102	0.00344	CbGpPWpGaD
Hydroxocobalamin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00201	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00101	0.00201	CcSEcCtD
Hydroxocobalamin—Tachycardia—Lisinopril—systemic scleroderma	0.00101	0.002	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Azathioprine—systemic scleroderma	0.00101	0.002	CcSEcCtD
Hydroxocobalamin—CASP9—AGE/RAGE pathway—MMP9—systemic scleroderma	0.00101	0.0034	CbGpPWpGaD
Hydroxocobalamin—Skin disorder—Lisinopril—systemic scleroderma	0.001	0.00199	CcSEcCtD
Hydroxocobalamin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.001	0.00199	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Captopril—systemic scleroderma	0.000999	0.00198	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000991	0.00197	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000991	0.00197	CcSEcCtD
Hydroxocobalamin—Nausea—Mometasone—systemic scleroderma	0.000987	0.00196	CcSEcCtD
Hydroxocobalamin—Pain—Mycophenolic acid—systemic scleroderma	0.000981	0.00195	CcSEcCtD
Hydroxocobalamin—TCN1—Disease—HSPG2—systemic scleroderma	0.000981	0.00331	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—SMAD7—systemic scleroderma	0.000981	0.00331	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HSPG2—systemic scleroderma	0.000981	0.00331	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—CD247—systemic scleroderma	0.000974	0.00329	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—TGFBI—systemic scleroderma	0.000972	0.00328	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—IL1A—systemic scleroderma	0.000968	0.00327	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Captopril—systemic scleroderma	0.000965	0.00192	CcSEcCtD
Hydroxocobalamin—CASP9—Corticotropin-releasing hormone—NOS3—systemic scleroderma	0.000961	0.00325	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Leflunomide—systemic scleroderma	0.000956	0.0019	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Leflunomide—systemic scleroderma	0.000951	0.00189	CcSEcCtD
Hydroxocobalamin—TCN1—Disease—CSK—systemic scleroderma	0.000947	0.0032	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CSK—systemic scleroderma	0.000947	0.0032	CbGpPWpGaD
Hydroxocobalamin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000946	0.00188	CcSEcCtD
Hydroxocobalamin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000945	0.00188	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000938	0.00186	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000938	0.00186	CcSEcCtD
Hydroxocobalamin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000933	0.00185	CcSEcCtD
Hydroxocobalamin—CASP9—Alzheimers Disease—IL1B—systemic scleroderma	0.000924	0.00312	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—IL1B—systemic scleroderma	0.000924	0.00312	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Lisinopril—systemic scleroderma	0.000922	0.00183	CcSEcCtD
Hydroxocobalamin—Rash—Captopril—systemic scleroderma	0.00092	0.00183	CcSEcCtD
Hydroxocobalamin—Dermatitis—Captopril—systemic scleroderma	0.000919	0.00183	CcSEcCtD
Hydroxocobalamin—Headache—Captopril—systemic scleroderma	0.000914	0.00182	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—HSPG2—systemic scleroderma	0.000912	0.00308	CbGpPWpGaD
Hydroxocobalamin—Dyspepsia—Lisinopril—systemic scleroderma	0.00091	0.00181	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000907	0.0018	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000906	0.0018	CcSEcCtD
Hydroxocobalamin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000906	0.0018	CcSEcCtD
Hydroxocobalamin—Infection—Mycophenolate mofetil—systemic scleroderma	0.0009	0.00179	CcSEcCtD
Hydroxocobalamin—MMACHC—Metabolism—HSPG2—systemic scleroderma	0.000898	0.00303	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TGFBI—systemic scleroderma	0.000897	0.00303	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000892	0.00177	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	0.000892	0.00301	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CD247—systemic scleroderma	0.00089	0.00301	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—CD247—systemic scleroderma	0.00089	0.00301	CbGpPWpGaD
Hydroxocobalamin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000888	0.00176	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000886	0.00176	CcSEcCtD
Hydroxocobalamin—Pain—Lisinopril—systemic scleroderma	0.000884	0.00176	CcSEcCtD
Hydroxocobalamin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000884	0.00176	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—CSK—systemic scleroderma	0.00088	0.00297	CbGpPWpGaD
Hydroxocobalamin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00088	0.00175	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Azathioprine—systemic scleroderma	0.000872	0.00173	CcSEcCtD
Hydroxocobalamin—Nausea—Captopril—systemic scleroderma	0.000867	0.00172	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000865	0.00172	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000852	0.00169	CcSEcCtD
Hydroxocobalamin—Pruritus—Leflunomide—systemic scleroderma	0.000851	0.00169	CcSEcCtD
Hydroxocobalamin—Dizziness—Azathioprine—systemic scleroderma	0.000842	0.00167	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—CD247—systemic scleroderma	0.000828	0.0028	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Leflunomide—systemic scleroderma	0.000823	0.00163	CcSEcCtD
Hydroxocobalamin—TCN1—Metabolism—HSPG2—systemic scleroderma	0.000821	0.00277	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—HSPG2—systemic scleroderma	0.000821	0.00277	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Lisinopril—systemic scleroderma	0.000821	0.00163	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Lisinopril—systemic scleroderma	0.000817	0.00162	CcSEcCtD
Hydroxocobalamin—AMN—Disease—HSPG2—systemic scleroderma	0.000813	0.00275	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HSPG2—systemic scleroderma	0.000813	0.00275	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000812	0.00161	CcSEcCtD
Hydroxocobalamin—Eye disorder—Prednisone—systemic scleroderma	0.000808	0.0016	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000807	0.0016	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—SMAD7—systemic scleroderma	0.000805	0.00272	CbGpPWpGaD
Hydroxocobalamin—Rash—Azathioprine—systemic scleroderma	0.000803	0.0016	CcSEcCtD
Hydroxocobalamin—Dermatitis—Azathioprine—systemic scleroderma	0.000802	0.00159	CcSEcCtD
Hydroxocobalamin—Headache—Azathioprine—systemic scleroderma	0.000798	0.00159	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000797	0.00158	CcSEcCtD
Hydroxocobalamin—Dizziness—Leflunomide—systemic scleroderma	0.000795	0.00158	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000785	0.00156	CcSEcCtD
Hydroxocobalamin—AMN—Disease—CSK—systemic scleroderma	0.000785	0.00265	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CSK—systemic scleroderma	0.000785	0.00265	CbGpPWpGaD
Hydroxocobalamin—Angiopathy—Prednisone—systemic scleroderma	0.000784	0.00156	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000782	0.00155	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Prednisone—systemic scleroderma	0.00078	0.00155	CcSEcCtD
Hydroxocobalamin—MUT—Disease—HSPG2—systemic scleroderma	0.000775	0.00262	CbGpPWpGaD
Hydroxocobalamin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000774	0.00154	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Prednisone—systemic scleroderma	0.000772	0.00153	CcSEcCtD
Hydroxocobalamin—TCN2—Metabolism—HSPG2—systemic scleroderma	0.000763	0.00258	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000762	0.00151	CcSEcCtD
Hydroxocobalamin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000759	0.00151	CcSEcCtD
Hydroxocobalamin—Rash—Leflunomide—systemic scleroderma	0.000758	0.00151	CcSEcCtD
Hydroxocobalamin—Dermatitis—Leflunomide—systemic scleroderma	0.000758	0.00151	CcSEcCtD
Hydroxocobalamin—Mental disorder—Prednisone—systemic scleroderma	0.000757	0.0015	CcSEcCtD
Hydroxocobalamin—Nausea—Azathioprine—systemic scleroderma	0.000757	0.0015	CcSEcCtD
Hydroxocobalamin—Headache—Leflunomide—systemic scleroderma	0.000754	0.0015	CcSEcCtD
Hydroxocobalamin—Erythema—Prednisone—systemic scleroderma	0.000752	0.00149	CcSEcCtD
Hydroxocobalamin—MUT—Disease—CSK—systemic scleroderma	0.000749	0.00253	CbGpPWpGaD
Hydroxocobalamin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000746	0.00148	CcSEcCtD
Hydroxocobalamin—AMN—Disease—CD247—systemic scleroderma	0.000738	0.00249	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CD247—systemic scleroderma	0.000738	0.00249	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TGFBI—systemic scleroderma	0.000737	0.00249	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Lisinopril—systemic scleroderma	0.000731	0.00145	CcSEcCtD
Hydroxocobalamin—Rash—Mycophenolic acid—systemic scleroderma	0.000724	0.00144	CcSEcCtD
Hydroxocobalamin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000723	0.00144	CcSEcCtD
Hydroxocobalamin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000719	0.00143	CcSEcCtD
Hydroxocobalamin—Headache—Mycophenolic acid—systemic scleroderma	0.000719	0.00143	CcSEcCtD
Hydroxocobalamin—CASP9—Allograft Rejection—TGFB1—systemic scleroderma	0.000718	0.00242	CbGpPWpGaD
Hydroxocobalamin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000716	0.00142	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—HSPG2—systemic scleroderma	0.000715	0.00242	CbGpPWpGaD
Hydroxocobalamin—Nausea—Leflunomide—systemic scleroderma	0.000715	0.00142	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000713	0.00142	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Methotrexate—systemic scleroderma	0.000708	0.00141	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Lisinopril—systemic scleroderma	0.000707	0.0014	CcSEcCtD
Hydroxocobalamin—MUT—Disease—CD247—systemic scleroderma	0.000704	0.00238	CbGpPWpGaD
Hydroxocobalamin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000698	0.00139	CcSEcCtD
Hydroxocobalamin—Agitation—Prednisone—systemic scleroderma	0.000691	0.00137	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—CSK—systemic scleroderma	0.000691	0.00233	CbGpPWpGaD
Hydroxocobalamin—Angioedema—Prednisone—systemic scleroderma	0.000687	0.00137	CcSEcCtD
Hydroxocobalamin—Dizziness—Lisinopril—systemic scleroderma	0.000684	0.00136	CcSEcCtD
Hydroxocobalamin—Nausea—Mycophenolic acid—systemic scleroderma	0.000682	0.00135	CcSEcCtD
Hydroxocobalamin—AMN—Metabolism—HSPG2—systemic scleroderma	0.000681	0.0023	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—HSPG2—systemic scleroderma	0.000681	0.0023	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—CTGF—systemic scleroderma	0.000681	0.0023	CbGpPWpGaD
Hydroxocobalamin—Malaise—Prednisone—systemic scleroderma	0.000678	0.00135	CcSEcCtD
Hydroxocobalamin—Eye disorder—Methotrexate—systemic scleroderma	0.000675	0.00134	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Methotrexate—systemic scleroderma	0.00067	0.00133	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000667	0.00133	CcSEcCtD
Hydroxocobalamin—MTR—Disease—SMAD7—systemic scleroderma	0.000656	0.00222	CbGpPWpGaD
Hydroxocobalamin—Angiopathy—Methotrexate—systemic scleroderma	0.000655	0.0013	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Methotrexate—systemic scleroderma	0.000652	0.0013	CcSEcCtD
Hydroxocobalamin—Rash—Lisinopril—systemic scleroderma	0.000652	0.00129	CcSEcCtD
Hydroxocobalamin—Dermatitis—Lisinopril—systemic scleroderma	0.000651	0.00129	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000651	0.00129	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—CD247—systemic scleroderma	0.00065	0.00219	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—HSPG2—systemic scleroderma	0.000649	0.00219	CbGpPWpGaD
Hydroxocobalamin—Chills—Methotrexate—systemic scleroderma	0.000648	0.00129	CcSEcCtD
Hydroxocobalamin—Headache—Lisinopril—systemic scleroderma	0.000648	0.00129	CcSEcCtD
Hydroxocobalamin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000641	0.00127	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000636	0.00126	CcSEcCtD
Hydroxocobalamin—CASP9—Corticotropin-releasing hormone—TGFB1—systemic scleroderma	0.000635	0.00215	CbGpPWpGaD
Hydroxocobalamin—Discomfort—Prednisone—systemic scleroderma	0.000633	0.00126	CcSEcCtD
Hydroxocobalamin—Mental disorder—Methotrexate—systemic scleroderma	0.000633	0.00126	CcSEcCtD
Hydroxocobalamin—Erythema—Methotrexate—systemic scleroderma	0.000629	0.00125	CcSEcCtD
Hydroxocobalamin—MMAB—Metabolism—CTGF—systemic scleroderma	0.000622	0.0021	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—CTGF—systemic scleroderma	0.000622	0.0021	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CSK—systemic scleroderma	0.000622	0.0021	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00062	0.00123	CcSEcCtD
Hydroxocobalamin—Nausea—Lisinopril—systemic scleroderma	0.000614	0.00122	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000614	0.00122	CcSEcCtD
Hydroxocobalamin—Oedema—Prednisone—systemic scleroderma	0.000614	0.00122	CcSEcCtD
Hydroxocobalamin—Infection—Prednisone—systemic scleroderma	0.00061	0.00121	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—ITGAM—systemic scleroderma	0.000609	0.00206	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CD247—systemic scleroderma	0.000609	0.00206	CbGpPWpGaD
Hydroxocobalamin—Nervous system disorder—Prednisone—systemic scleroderma	0.000602	0.0012	CcSEcCtD
Hydroxocobalamin—MTR—Disease—TGFBI—systemic scleroderma	0.0006	0.00203	CbGpPWpGaD
Hydroxocobalamin—Tachycardia—Prednisone—systemic scleroderma	0.000599	0.00119	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism—HSPG2—systemic scleroderma	0.000599	0.00202	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000599	0.00119	CcSEcCtD
Hydroxocobalamin—Skin disorder—Prednisone—systemic scleroderma	0.000596	0.00118	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—HSPG2—systemic scleroderma	0.000587	0.00198	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD247—systemic scleroderma	0.000585	0.00198	CbGpPWpGaD
Hydroxocobalamin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000583	0.00116	CcSEcCtD
Hydroxocobalamin—TCN2—Metabolism—CTGF—systemic scleroderma	0.000579	0.00195	CbGpPWpGaD
Hydroxocobalamin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000571	0.00113	CcSEcCtD
Hydroxocobalamin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000571	0.00113	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—TNFAIP3—systemic scleroderma	0.00057	0.00193	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CSK—systemic scleroderma	0.000567	0.00192	CbGpPWpGaD
Hydroxocobalamin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000567	0.00113	CcSEcCtD
Hydroxocobalamin—Malaise—Methotrexate—systemic scleroderma	0.000567	0.00113	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—MMP9—systemic scleroderma	0.000548	0.00185	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—BLK—systemic scleroderma	0.000541	0.00183	CbGpPWpGaD
Hydroxocobalamin—Dyspepsia—Prednisone—systemic scleroderma	0.00054	0.00107	CcSEcCtD
Hydroxocobalamin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000538	0.00107	CcSEcCtD
Hydroxocobalamin—Chest pain—Methotrexate—systemic scleroderma	0.000535	0.00106	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—CD247—systemic scleroderma	0.000533	0.0018	CbGpPWpGaD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000532	0.00106	CcSEcCtD
Hydroxocobalamin—Discomfort—Methotrexate—systemic scleroderma	0.000529	0.00105	CcSEcCtD
Hydroxocobalamin—MMAA—Metabolism—CTGF—systemic scleroderma	0.000516	0.00174	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—CTGF—systemic scleroderma	0.000516	0.00174	CbGpPWpGaD
Hydroxocobalamin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000513	0.00102	CcSEcCtD
Hydroxocobalamin—Infection—Methotrexate—systemic scleroderma	0.00051	0.00101	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Prednisone—systemic scleroderma	0.000506	0.001	CcSEcCtD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—IL1B—systemic scleroderma	0.000505	0.00171	CbGpPWpGaD
Hydroxocobalamin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000503	0.000999	CcSEcCtD
Hydroxocobalamin—Skin disorder—Methotrexate—systemic scleroderma	0.000498	0.00099	CcSEcCtD
Hydroxocobalamin—CASP9—Disease—SMAD7—systemic scleroderma	0.000494	0.00167	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—CTGF—systemic scleroderma	0.000492	0.00166	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—HSPG2—systemic scleroderma	0.000492	0.00166	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Prednisone—systemic scleroderma	0.000488	0.000969	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Prednisone—systemic scleroderma	0.000485	0.000964	CcSEcCtD
Hydroxocobalamin—MTR—Disease—HSPG2—systemic scleroderma	0.000479	0.00162	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CSK—systemic scleroderma	0.000463	0.00156	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Methotrexate—systemic scleroderma	0.000457	0.000909	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism—CTGF—systemic scleroderma	0.000454	0.00153	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Prednisone—systemic scleroderma	0.000452	0.000898	CcSEcCtD
Hydroxocobalamin—CASP9—Disease—TGFBI—systemic scleroderma	0.000452	0.00153	CbGpPWpGaD
Hydroxocobalamin—Dyspepsia—Methotrexate—systemic scleroderma	0.000452	0.000897	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—CTLA4—systemic scleroderma	0.000443	0.0015	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000443	0.00088	CcSEcCtD
Hydroxocobalamin—Pain—Methotrexate—systemic scleroderma	0.000439	0.000872	CcSEcCtD
Hydroxocobalamin—MTR—Disease—CD247—systemic scleroderma	0.000435	0.00147	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Prednisone—systemic scleroderma	0.000434	0.000863	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000423	0.00084	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Prednisone—systemic scleroderma	0.00042	0.000834	CcSEcCtD
Hydroxocobalamin—Urticaria—Methotrexate—systemic scleroderma	0.000408	0.00081	CcSEcCtD
Hydroxocobalamin—Dizziness—Prednisone—systemic scleroderma	0.000406	0.000806	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Methotrexate—systemic scleroderma	0.000406	0.000806	CcSEcCtD
Hydroxocobalamin—MTR—Metabolism—HSPG2—systemic scleroderma	0.000401	0.00136	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TGFB1—systemic scleroderma	0.000392	0.00133	CbGpPWpGaD
Hydroxocobalamin—Rash—Prednisone—systemic scleroderma	0.000387	0.000769	CcSEcCtD
Hydroxocobalamin—Dermatitis—Prednisone—systemic scleroderma	0.000387	0.000768	CcSEcCtD
Hydroxocobalamin—Headache—Prednisone—systemic scleroderma	0.000385	0.000764	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000378	0.000751	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—CSK—systemic scleroderma	0.000377	0.00127	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CTGF—systemic scleroderma	0.000373	0.00126	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IRF5—systemic scleroderma	0.000371	0.00125	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.000365	0.00123	CbGpPWpGaD
Hydroxocobalamin—Nausea—Prednisone—systemic scleroderma	0.000365	0.000724	CcSEcCtD
Hydroxocobalamin—Pruritus—Methotrexate—systemic scleroderma	0.000363	0.000721	CcSEcCtD
Hydroxocobalamin—CASP9—Disease—HSPG2—systemic scleroderma	0.000361	0.00122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IRF8—systemic scleroderma	0.000355	0.0012	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ITGAM—systemic scleroderma	0.000355	0.0012	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD247—systemic scleroderma	0.000355	0.0012	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	0.000354	0.0012	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—NOS3—systemic scleroderma	0.000354	0.0012	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Methotrexate—systemic scleroderma	0.000351	0.000697	CcSEcCtD
Hydroxocobalamin—CASP9—Disease—CSK—systemic scleroderma	0.000348	0.00118	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SMAD7—systemic scleroderma	0.000346	0.00117	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD40LG—systemic scleroderma	0.000345	0.00116	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Methotrexate—systemic scleroderma	0.000339	0.000674	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—TNFAIP3—systemic scleroderma	0.000332	0.00112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BLK—systemic scleroderma	0.000328	0.00111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CD247—systemic scleroderma	0.000327	0.00111	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—NOS3—systemic scleroderma	0.000323	0.00109	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—NOS3—systemic scleroderma	0.000323	0.00109	CbGpPWpGaD
Hydroxocobalamin—Rash—Methotrexate—systemic scleroderma	0.000323	0.000643	CcSEcCtD
Hydroxocobalamin—Dermatitis—Methotrexate—systemic scleroderma	0.000323	0.000642	CcSEcCtD
Hydroxocobalamin—Headache—Methotrexate—systemic scleroderma	0.000321	0.000638	CcSEcCtD
Hydroxocobalamin—Nausea—Methotrexate—systemic scleroderma	0.000305	0.000605	CcSEcCtD
Hydroxocobalamin—MTR—Metabolism—CTGF—systemic scleroderma	0.000304	0.00103	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—NOS3—systemic scleroderma	0.000301	0.00102	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—NOS3—systemic scleroderma	0.000296	0.001	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—NOS3—systemic scleroderma	0.000271	0.000915	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—NOS3—systemic scleroderma	0.000271	0.000915	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CTLA4—systemic scleroderma	0.000269	0.000908	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NOS3—systemic scleroderma	0.000268	0.000906	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NOS3—systemic scleroderma	0.000268	0.000906	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RHOB—systemic scleroderma	0.000268	0.000905	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NOS3—systemic scleroderma	0.000256	0.000864	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HSPG2—systemic scleroderma	0.000252	0.000853	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—NOS3—systemic scleroderma	0.000252	0.000851	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CSK—systemic scleroderma	0.000244	0.000824	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NOS3—systemic scleroderma	0.000236	0.000797	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—TGFB1—systemic scleroderma	0.000234	0.00079	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—NOS3—systemic scleroderma	0.000224	0.000758	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—NOS3—systemic scleroderma	0.000224	0.000758	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-DQB1—systemic scleroderma	0.000221	0.000748	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—NOS3—systemic scleroderma	0.000214	0.000724	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—TGFB1—systemic scleroderma	0.000214	0.000723	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—TGFB1—systemic scleroderma	0.000214	0.000723	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL1A—systemic scleroderma	0.00021	0.00071	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD40LG—systemic scleroderma	0.000209	0.000706	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—TGFB1—systemic scleroderma	0.000199	0.000672	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—NOS3—systemic scleroderma	0.000198	0.000668	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NOS3—systemic scleroderma	0.000194	0.000655	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—TGFB1—systemic scleroderma	0.000177	0.000599	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—TGFB1—systemic scleroderma	0.000177	0.000599	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—TGFB1—systemic scleroderma	0.000169	0.000571	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—NOS3—systemic scleroderma	0.000162	0.000548	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOS3—systemic scleroderma	0.000158	0.000534	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TGFB1—systemic scleroderma	0.000156	0.000527	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EDN1—systemic scleroderma	0.000137	0.000462	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—NOS3—systemic scleroderma	0.000132	0.000447	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TGFB1—systemic scleroderma	0.000128	0.000433	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS3—systemic scleroderma	0.000119	0.000402	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL1B—systemic scleroderma	0.00011	0.00037	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TGFB1—systemic scleroderma	0.000104	0.000353	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCL2—systemic scleroderma	9.34e-05	0.000316	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOS3—systemic scleroderma	8.33e-05	0.000281	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TGFB1—systemic scleroderma	7.86e-05	0.000266	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—systemic scleroderma	6.68e-05	0.000226	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFB1—systemic scleroderma	5.51e-05	0.000186	CbGpPWpGaD
